The Ministry of Health of the Russian Federation, in accordance with Article 32 of Federal Law No. 61-FZ of 12.04.2010 "On circulation of medicines", decided to abolish state registration and exclusionfrom the state register of medicinal products for the medical use of the medicinal product (registration certificate LP-002260 dated 01.10.2013 issued by Zentiva, Czech Republic):
Clopidogrel (trade name of the medicinal product)
Clopidogrel (international non-proprietary or grouping or chemical name)
film-coated tablets, 75 mg (dosage form, dosage)
Zentiva, Czech Republic U kabelovny 130, 102 37 Prague 10, Dolni Mecholupy, Czech Republic (name and address of the location of the manufacturer of the medicinal product)
on the basis of a filing by an authorized legal entity of the Representative Office of Sanofi-aventis Group, state registration of medicinal product.